Table 1.

A: EMSA Probes. Positions of probes are given relative to TSP. Putative NRF-2 binding sites are underlined.
Gene Promoter	Position	EMSA Sequence
Gria1	+198/+221	F: 5′ TTTTAGAAGGAAGGGAGGAAGGAAAGAA 3′
		R: 5′ TTTTTTCTTTCCTTCCTCCCTTCCTTCT 3′
Gria2	−327/−298	F: 5′ TTTTCGGCTTCCTAGGCATAGCAACCGGAAATCA 3′
		R: 5′ TTTTTGATTTCCGGTTGCTATGCCTAGGAAGCCG 3′
Gria3	+101/+117	F: 5′ TTTTGGGTGGAAAGGAAGAGT 3′
		R: 5′ TTTTACTCTTCCTTTCCACCC 3′
Gria4	+403/+420	F: 5′ TTTTTGGGGGAAAGGGAATGGG 3′
		R: 5′ TTTTCCCATTCCCTTTCCCCCA 3′
COX6b	−47/−23	F: 5′ TTTTTCCTCTTGCAGCTTCCGGCCAGTC 3′
		R: 5′ TTTTGACTGGCCGGAAGCTGCAAGAGGA 3′

B: Mutant EMSA Probes. Positions of probes are given relative to TSP. Mutated NRF-2 binding sites are underlined.
Gene Promoter	Position	Sequence
Gria1	+198/+221	F: 5′ TTTTAGAATTTTGGGAGGTTTTAAAGAA 3′
		R: 5′ TTTTTTCTTTAAAACCTCCCAAAATTCT 3′
Gria2	−327/−298	F: 5′ TTTTCGGCAAAATAGGCATAGCAACCTTTTATCA 3′
		R: 5′ TTTTTGATAAAAGGTTGCTATGCCTATTTTGCCG 3′